myfortic 2 x 360 mg, bid MMF 2 x 500 mg, bid Morning Evening CellCept CellCept CellCept CellCept
Kidney Transplant Medication - enteric-coated myfortic mycophenolic acid delayed-release tablet





Healthcare Professionals



Renal Transplant Patient Handout

Important myfortic Trials




Important Safety Information
  Novartis Pharma US

 
myfortic: Dosing


Understanding myfortic® Dosing


Smaller-sized tablets compared to MMF

21% smaller in width
10% smaller in volume

Dosing With myfortic® Means Smaller Tablets

The recommended dose for myfortic is 720 mg bid

MMF to myfortic® Dosing Conversion Chart
      Patient's myfortic® Dosing Schedule
MMF myfortic® myfortic®
Prescription written as:
Morning Evening
2000 mg MMR 1440 mg/day myfortic 720 mg myfortic bid
or 2 x 360 mg
myfortic bid
1500 mg MMF 1080 mg/day myfortic 180 mg myfortic bid
360 mg myfortic bid
1000 mg MMF 720 mg/day myfortic 360 mg myfortic bid
500 mg MMF 360 mg/day myfortic 180 mg myfortic bid
The equimolar doses are:
250 mg MMF - 180 mg myfortic
500 mg MMF - 360 mg myfortic

The recommended dose of myfortic is 720 mg administered twice daily (1440 mg total daily dose) on an empty stomach, 1 hour before or 2 hours after food intake.

myfortic delayed-release tablets and mycophenolate mofetil tablets and capsules should not be used interchangeably without physician supervision because the rate of absorption following the administration of these 2 products is not equivalent.

720 mg of myfortic delivers the same amount (equimolar) MPA as 1000 mg of MMF

Click here for full prescribing information, which includes contraindications, warnings, precautions, and adverse events.

Back to top 




CellCept® is a registered trademark of Roche Laboratories, Inc.

myfortic Home | Healthcare Professionals Home | myfortic: It's All in the Delivery Renal Transplant Resources | Renal Transplant Patient Handout Important myfortic Trials | Reimbursement Information Prescribing Information | Important Safety Information Site Guide | Site Map | Contact Us
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.